According to Bristol-Myers Squibb's latest financial reports the company's current earnings are $47.63 Billion USD. In 2024 the company made an earning of -$8.38 Billion USD a decrease over its 2023 earnings that were of $8.44 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | $6.10 B | -172.9% |
2024 | -$8.38 Billion | -199.28% |
2023 | $8.44 B | 9.43% |
2022 | $7.71 B | -4.75% |
2021 | $8.09 B | -217.86% |
2020 | -$6.88 Billion | -238.11% |
2019 | $4.97 B | -16.64% |
2018 | $5.96 B | 16.31% |
2017 | $5.13 B | -13.25% |
2016 | $5.91 B | 184.79% |
2015 | $2.07 B | -12.77% |
2014 | $2.38 B | -17.64% |
2013 | $2.89 B | 23.55% |
2012 | $2.34 B | -66.48% |
2011 | $6.98 B | 14.99% |
2010 | $6.07 B | 20.58% |
2009 | $5.03 B | -7.97% |
2008 | $5.47 B | 74.12% |
2007 | $3.14 B | 19.24% |
2006 | $2.63 B | -41.65% |
2005 | $4.51 B | 2.59% |
2004 | $4.40 B | -10.76% |
2003 | $4.93 B | 86.36% |
2002 | $2.64 B | -6.27% |
2001 | $2.82 B | -49.72% |
2000 | $5.61 B | 0.45% |
1999 | $5.59 B | 31% |
1998 | $4.26 B | -4.77% |
1997 | $4.48 B | 11.69% |
1996 | $4.01 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $10.34 B | 69.30% | ๐บ๐ธ USA |
![]() Merck MRK | $21.45 B | 251.18% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $13.60 B | 122.67% | ๐บ๐ธ USA |
![]() Novartis NVS | $14.91 B | 144.24% | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | $8.76 B | 43.57% | ๐ซ๐ท France |
![]() AstraZeneca AZN | $10.97 B | 79.62% | ๐ฌ๐ง UK |
![]() Johnson & Johnson JNJ | $27.40 B | 348.72% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $3.62 B | -40.70% | ๐บ๐ธ USA |
![]() Amgen AMGN | $6.65 B | 8.87% | ๐บ๐ธ USA |
![]() Biogen BIIB | $1.75 B | -71.31% | ๐บ๐ธ USA |